Key Takeaways Umbilical cord MSCs for stroke are being studied as a possible add-on to standard rehabilitation, not a replacement for it. A 2025 randomized trial in 32 patients found
Key Takeaways Stem cells for disc degeneration can be delivered in two ways: intradiscal injection straight into the disc, or IV infusion through a vein. A 2014 mouse study found
Key Takeaways A one-year Parkinson’s stem cell trial called STEM-PD found no serious side effects linked to the cell product itself. Scientists used embryonic stem cells to grow dopamine producing
Key Takeaways Chronic, low-grade inflammation and insulin resistance drive each other in a two-way loop that starts largely in visceral fat. Mesenchymal stem cells are being studied for their ability
Key Takeaways Stem cell therapy for rheumatoid arthritis has real human trial data behind it, not just lab or animal studies. A 3-year study found that disease activity scores significantly
Key Takeaways Novartis paused eight autoimmune and nerve disease trials of its rap-cel CAR-T cell therapy on August 24, 2026. Three patients died from immune effector cell-associated hemophagocytic syndrome (IEC-HS).
